[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610372":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":19,"studyPopulation":11,"armGroups":20,"interventions":26,"overallOfficials":11,"centralContacts":32,"locations":38,"responsibleParty":82,"collaborators":11,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":11,"eligibilityCriteria":90,"healthyVolunteers":86,"sex":91,"minAge":92,"maxAge":11,"enrollmentInfo":93,"targetDuration":11,"studyType":96,"phases":97,"briefSummary":99,"conditions":100,"keywords":102,"overallStatus":41,"whyStopped":11,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"The Foundation for Orthopaedics and Regenerative Medicine","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Oxygen Saturation",null,"From enrollment to 6 months after treatment",{"allocation":14,"interventionModel":15,"interventionModelDescription":11,"primaryPurpose":16,"observationalModel":11,"timePerspective":11,"maskingInfo":17},"NA","SINGLE_GROUP","TREATMENT",{"masking":18,"maskingDescription":11,"whoMasked":11},"NONE","Single Arm non-controlled study. Patients are prospectively evaluated then treated. Outcomes are tracked after treatment.",[21],{"label":22,"type":23,"description":11,"interventionNames":24},"Treatment Group","EXPERIMENTAL",[25],"Biological: AlloEx exosomes",[27],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":11},"BIOLOGICAL","AlloEx exosomes","This is an intranasal treatment of exosomes derived from mesenchymal stem cells.",[22],[33],{"name":34,"role":35,"phone":36,"phoneExt":11,"email":37},"Chadwick Prodromos","CONTACT","18476996810","care@thepsci.com",[39,57,68],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Prodromos Stem Cell Institute","RECRUITING","Naples","Florida","34102","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-81.79596,26.14234,{"lat":51,"lon":50},[54],{"name":55,"role":35,"phone":56,"phoneExt":11,"email":37},"Chadwick Prodromos, MD","847-699-6810",{"facility":40,"status":41,"city":58,"state":59,"zip":60,"country":45,"countryCode":46,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Irving","Texas","75039",{"type":48,"coordinates":62},[63,64],-96.94889,32.81402,{"lat":64,"lon":63},[67],{"name":55,"role":35,"phone":56,"phoneExt":11,"email":37},{"facility":69,"status":41,"city":70,"state":11,"zip":11,"country":71,"countryCode":72,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Medical Surgical Associates Center","St John's","Antigua and Barbuda","AG",{"type":48,"coordinates":74},[75,76],-61.84329,17.12096,{"lat":76,"lon":75},[79],{"name":55,"role":35,"phone":80,"phoneExt":11,"email":81},"2684845200","research@ismoc.net",{"type":83,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100610372","phase-1-patients-with-congenital-myasthenic-syndrome-will-be-treated-with-mesenchymal-stem-cell-exosome-solution-100610372",false,"NCT07226726","Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution","Mesenchymal Stem Cell Exosome Treatment of Congenital Myasthenic Syndrome","Inclusion Criteria:\n\n* Patients will need a diagnosis of Congenital Myasthenic Syndrome by a licensed physician.\n* Patients must be able to provide informed consent, or have a guardian who does.\n* Patient must be able to travel to the site of treatment.\n\nExclusion Criteria:\n\n* Patients will be excluded from the trial if they are pregnant or have active cancer (malignancy) at the screening consultation.","ALL","18 Years",{"count":94,"type":95},20,"ESTIMATED","INTERVENTIONAL",[98],"PHASE1","Patients with Congenital Myasthenic Syndrome will be treated with Mesenchymal Stem Cell Exosome solution.",[101],"Congenital Myasthenic Syndrome",[103,104,101],"exosomes","secretome","2025-11-06",{"date":107,"type":108},"2025-11-10","ACTUAL",{"date":110,"type":108},"2025-01-01",{"date":112,"type":95},"2028-12-31",{"name":5,"class":6},3]